Patients with bipolar disorder are at high risk of gaining weight and developing metabolic illnesses, and pharmacologic treatment for the disorder may significantly increase this risk. This paper reviews the literature on the metabolic consequences of the medications used in bipolar disorder and describes the possible strategies to prevent, monitor, and treat the common metabolic illnesses that patients with bipolar disorder may develop during treatment. Copyright © 2007 by Current Medicine Group LLC.
Fagiolini, A., Chengappa, K.N.R. (2007). Weight gain and metabolic issues of medicines used for bipolar disorder. CURRENT PSYCHIATRY REPORTS, 9(6), 521-528 [10.1007/s11920-007-0071-1].
Weight gain and metabolic issues of medicines used for bipolar disorder
FAGIOLINI, ANDREA;
2007-01-01
Abstract
Patients with bipolar disorder are at high risk of gaining weight and developing metabolic illnesses, and pharmacologic treatment for the disorder may significantly increase this risk. This paper reviews the literature on the metabolic consequences of the medications used in bipolar disorder and describes the possible strategies to prevent, monitor, and treat the common metabolic illnesses that patients with bipolar disorder may develop during treatment. Copyright © 2007 by Current Medicine Group LLC.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Weight_Gain_and_Metabolic_Issues_of.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
171.64 kB
Formato
Adobe PDF
|
171.64 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/12158
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo